CNSP
Price
$5.32
Change
+$0.11 (+2.11%)
Updated
Oct 2, 04:58 PM (EDT)
Capitalization
7.47M
47 days until earnings call
Intraday BUY SELL Signals
PMN
Price
$9.28
Change
-$0.10 (-1.07%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
95.51M
Intraday BUY SELL Signals
Interact to see
Advertisement

CNSP vs PMN

CNSP vs PMN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CNSP vs. PMN commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Hold and PMN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CNSP vs PMN: Fundamental Ratings
CNSP
PMN
OUTLOOK RATING
1..100
9465
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4063
P/E GROWTH RATING
1..100
9898
SEASONALITY SCORE
1..100
5018

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNSP's Valuation (6) in the null industry is significantly better than the same rating for PMN (89). This means that CNSP’s stock grew significantly faster than PMN’s over the last 12 months.

CNSP's Profit vs Risk Rating (100) in the null industry is in the same range as PMN (100). This means that CNSP’s stock grew similarly to PMN’s over the last 12 months.

CNSP's SMR Rating (99) in the null industry is in the same range as PMN (99). This means that CNSP’s stock grew similarly to PMN’s over the last 12 months.

CNSP's Price Growth Rating (40) in the null industry is in the same range as PMN (63). This means that CNSP’s stock grew similarly to PMN’s over the last 12 months.

CNSP's P/E Growth Rating (98) in the null industry is in the same range as PMN (98). This means that CNSP’s stock grew similarly to PMN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNSPPMN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (CNSP: $5.21 vs. PMN: $9.38)
Brand notoriety: CNSP and PMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 14% vs. PMN: 119%
Market capitalization -- CNSP: $7.47M vs. PMN: $95.51M
CNSP [@Biotechnology] is valued at $7.47M. PMN’s [@Biotechnology] market capitalization is $95.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 1 FA rating(s) are green while PMN’s FA Score has 0 green FA rating(s).

  • CNSP’s FA Score: 1 green, 4 red.
  • PMN’s FA Score: 0 green, 5 red.
According to our system of comparison, CNSP is a better buy in the long-term than PMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 4 TA indicator(s) are bullish while PMN’s TA Score has 4 bullish TA indicator(s).

  • CNSP’s TA Score: 4 bullish, 5 bearish.
  • PMN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CNSP is a better buy in the short-term than PMN.

Price Growth

CNSP (@Biotechnology) experienced а +5.68% price change this week, while PMN (@Biotechnology) price change was -18.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

CNSP is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CNSP
Daily Signal:
Gain/Loss:
PMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY13.950.23
+1.68%
Bally's Corporation
ZGN12.620.12
+0.96%
Ermenegildo Zegna NV
SKYE1.60-0.01
-0.62%
Skye Bioscience Inc
QSR69.76-1.32
-1.86%
Restaurant Brands International
VERI0.75-0.44
-37.03%
Veritone

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with PMN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
-1.70%
PMN - CNSP
51%
Loosely correlated
-13.55%
RLYB - CNSP
44%
Loosely correlated
-2.56%
ORMP - CNSP
38%
Loosely correlated
-4.07%
AURA - CNSP
34%
Loosely correlated
-3.82%
PTGX - CNSP
30%
Poorly correlated
-1.21%
More

PMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with CNSP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then CNSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
-13.55%
CNSP - PMN
51%
Loosely correlated
-1.70%
SYRE - PMN
44%
Loosely correlated
+1.01%
BBIO - PMN
42%
Loosely correlated
+1.69%
ABOS - PMN
33%
Poorly correlated
-6.76%
CTNM - PMN
33%
Poorly correlated
-3.20%
More